First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Clinical trial NCT01728259 · TERMINATED
Trial details
- NCT number
- NCT01728259
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2018-10-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.